Emile SH, Ragheb J. Toward less invasive coloproctology: The future is out there. World J Gastroenterol 2024; 30(3): 199-203 [PMID: 38314131 DOI: 10.3748/wjg.v30.i3.199]
Corresponding Author of This Article
Sameh Hany Emile, FACS, MBChB, MD, MS, Associate Professor, Doctor, Research Scientist, Department of Colorectal Surgery, Cleveland Clinic Florida, No. 2950 Cleveland Clinic Blvd, Weston, FL 33331, United States. sameh200@hotmail.com
Research Domain of This Article
Surgery
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Jan 21, 2024; 30(3): 199-203 Published online Jan 21, 2024. doi: 10.3748/wjg.v30.i3.199
Toward less invasive coloproctology: The future is out there
Sameh Hany Emile, Jonathan Ragheb
Sameh Hany Emile, Department of Colorectal Surgery, Cleveland Clinic Florida, Weston, FL 33331, United States
Jonathan Ragheb, Department of Gastroenterology and Hepatology, Cleveland Clinic Florida, Weston, FL 33331, United States
Author contributions: Emile SH contributed to the conception and writing of the manuscript; Ragheb J contributed to the critical revision of the manuscript; all authors have read and approved the final manuscript.
Conflict-of-interest statement: Sameh Emile and Jonathan Ragheb have no conflicts of interests to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Sameh Hany Emile, FACS, MBChB, MD, MS, Associate Professor, Doctor, Research Scientist, Department of Colorectal Surgery, Cleveland Clinic Florida, No. 2950 Cleveland Clinic Blvd, Weston, FL 33331, United States. sameh200@hotmail.com
Received: November 28, 2023 Peer-review started: November 28, 2023 First decision: December 8, 2023 Revised: December 12, 2023 Accepted: January 5, 2024 Article in press: January 5, 2024 Published online: January 21, 2024 Processing time: 50 Days and 17.9 Hours
Abstract
Medical care has undergone remarkable improvements over the past few decades. One of the most important innovative breakthroughs in modern medicine is the advent of minimally and less invasive treatments. The trend towards employing less invasive treatment has been vividly shown in the field of gastroenterology, particularly coloproctology. Parallel to foregut interventions, colorectal surgery has shifted towards a minimally invasive approach. Coloproctology, including both medical and surgical management of colorectal diseases, has undergone a remarkable paradigm shift. The treatment of both benign and malignant colorectal conditions has gradually transitioned towards more conservative and less invasive approaches. An interesting paradigm shift was the trend to avoid the need for radical resection of rectal cancer altogether in patients who showed complete response to neoadjuvant treatment. The trend of adopting less invasive approaches to treat various colorectal conditions does not seem to be stopping soon as further research on novel, more effective and safer methods is ongoing.
Core Tip: One of the most important innovative breakthroughs in modern medicine is the advent of minimally and less invasive treatments. Coloproctology has undergone a remarkable paradigm shift as the treatment of benign and malignant colorectal conditions has gradually transitioned towards less invasive approaches. An important paradigm shift was the trend to avoid the need for radical resection of rectal cancer altogether in patients who showed complete response to neoadjuvant treatment. Another example is the trend toward non-operative management of inflammatory bowel disease and benign anorectal disorders.
